期刊文献+

炭疽保护性抗原第四结构域基因在重组SFV复制子载体中的表达 被引量:2

Expression of domain 4 of protective antigen of anthrax in mammalian cells using recombinant Semliki forest virus replicon vectors
原文传递
导出
摘要 目的:构建炭疽毒素保护性抗原第四结构域PA4基因的重组Sem lik i森林病毒(Sem lik i forest virus,SFV)复制子载体,并观察PA4抗原在重组SFV复制子载体中的表达。方法:将PA4基因克隆到基于RNA和DNA的SFV复制子表达载体中,获得的重组SFV复制子载体直接转染BHK21细胞,通过间接免疫荧光和W estern印迹试验检测PA4在细胞中的表达;与辅助病毒载体共转染制备重组病毒颗粒,通过间接免疫荧光和W estern印迹检测PA4在重组病毒颗粒感染细胞中的表达。结果与结论:成功地构建了基于RNA和DNA的PA4重组SFV复制子载体,并且在体外基于RNA和DNA的重组SFV复制子表达载体能够在细胞中有效地表达非分泌型和分泌型的PA4抗原,制备了具有感染能力并能表达PA4抗原的重组病毒颗粒,为进一步以SFV复制子作疫苗载体观察炭疽新型复制子疫苗的免疫原性奠定了基础。 Objective: To construct recombinant Semliki forest virus(SFV) replieon vectors containing domain 4 of the protective antigen of anthrax ( PA4 ), and observe its expression in mammalian cells. Methods: PA4 Gene from anthrax toxin was cloned into RNA and DNA-based SFV replieon expression vectors, and these recombinant replicon expression vectors were named pSMPA4E, pSMSPA4E, pSCARPA4E, and pSCARSPA4E, respectively. Expression of antigen PA4 was confirmed by indirect (IF) and Western blot after transfecting BHK21 cells with these replieon expression vectors. Recombinant virus particles (RVP) were prepared by eotranfecting these expression vectors with helper vectors and expression of antigen PA4 was also confirmed by indirect immunofluoreseenee (IF) and Western blot in cells which were infected with these recombinant virus particles (RVP). Results and Conclusion: Recombinant SFV replieon vectors containing PA4 gene which could effectively express nonsecreting and secreting antigen PA4 in mammalian cells were successfully constructed. This work laid a foundation for the study of the immunogenieity of SFV replicon vaccines and provided an alternative way to develop new type vaccines against anthrax.
出处 《军事医学科学院院刊》 CSCD 北大核心 2006年第6期521-525,共5页 Bulletin of the Academy of Military Medical Sciences
关键词 Semliki森林病毒 复制子 炭疽毒素 保护性抗原 重组病毒颗粒 Semliki forest virus replicon anthrax toxin protective antigen recombinant virus particles (RVP)
  • 相关文献

参考文献12

  • 1Hermanson G,Whitlow V,Parker S,et al.A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores[J].Proc Natl Acad Sci USA,2004,101 (37):13601-13606.
  • 2Lee JS,Hadjipanayis AG,Welkos SL.Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge[J].Infect Immun,2003,71 (3):1491-1496.
  • 3Rayner JO,Dravga SA,Kamrud KI.Alphavirus vectors and vaccination[J].Rev Med Virol,2002,12(5):279-296.
  • 4Lundstrom K.Semliki Forest virus vectors for gene therapy[J].Expert Opin Biol Ther,2003,3(5):771-777.
  • 5Varughese M,Teixeira AV,Liu SH,et al.Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin[J].Infect Immun,1999,67 (4):1860-1865.
  • 6Flick-Smith HC,Walker NJ,Gibson P,et al.A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection[J].Infect Immun,2002,70 (3):1653-1656.
  • 7余云舟,孙志伟,俞炜源.基于DNA和RNA的双功能Semliki森林病毒复制子载体的构建[J].生物工程学报,2005,21(5):713-718. 被引量:7
  • 8余云舟,孙志伟,刘志刚,俞炜源.基于DNA的Semliki森林病毒复制子载体体内外高水平表达外源基因[J].生物化学与生物物理进展,2006,33(1):87-94. 被引量:9
  • 9余燕,孙志伟,沈应柏,俞炜源,陈学英.炭疽毒素保护性抗原第四结构域在大肠杆菌中的可溶性表达[J].生物技术通讯,2005,16(4):389-391. 被引量:2
  • 10Leitner WW,Hwang LN,deVeer MJ,et al.Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways[J].Nat Med,2003,9 (1):33-39.

二级参考文献33

  • 1余云舟,孙志伟,俞炜源.基于DNA和RNA的双功能Semliki森林病毒复制子载体的构建[J].生物工程学报,2005,21(5):713-718. 被引量:7
  • 2Lundstrom K. Alphavirus vectors for vaccines production and gene therapy. Expert Rev Vaccines, 2003, 2 (3): 447-459.
  • 3Xanthopoulos K G. Development of improved Sindbis virus-based DNA expression vector. DNA Cell Biol, 2004, 23 (2):75-80.
  • 4Polo J M, Belli B A, Driver D A, et al. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.Proc Natl Acad Sci USA, 1999, 96 (8): 4598 -4603.
  • 5Leitner W W, Hwang L N, Deveer M J, et ol. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med, 2003, 9 (I): 33-39.
  • 6Leitner W W, Ying H, Driver D A, et al. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors. Cancer Research, 2000, 60 (I): 51 -55.
  • 7Leitner W W, Hwang L N, Bergmann-Leitner E S, et ol. Apoptosis is essential for the increased efficacy of alphavirus-based DNA vaccines. Vaccine, 2004, 22 (11 - 12): 1537 - 1544.
  • 8Jonathan O R, Sergey A D, Kurt I K. Alphavirus vectors and vaccination. Rev Meal Virol, 2002, 12 (5): 279-296.
  • 9Lundstrom K. Semliki Forest virus vectors for gene therapy. Expert Opin Biol Ther, 2003, 3 (5): 771 -777.
  • 10Boyer J C, Haermi A L. Infectious transcripts and cDNA clones of RNA viruses. Virology, 1994, 198 (2): 415-426.

共引文献11

同被引文献23

  • 1余燕,孙志伟,沈应柏,俞炜源,陈学英.炭疽毒素保护性抗原第四结构域在大肠杆菌中的可溶性表达[J].生物技术通讯,2005,16(4):389-391. 被引量:2
  • 2余云舟,孙志伟,俞炜源.基于DNA和RNA的双功能Semliki森林病毒复制子载体的构建[J].生物工程学报,2005,21(5):713-718. 被引量:7
  • 3余云舟,孙志伟,刘志刚,俞炜源.基于DNA的Semliki森林病毒复制子载体体内外高水平表达外源基因[J].生物化学与生物物理进展,2006,33(1):87-94. 被引量:9
  • 4Lee J S,Hadjipanayis A G,Welkos S L.Venezuelan equine encephalitis virus-vectored vaccines protect mice against an-thrax spore challenge[J].Infect immun,2003,71(3):1491-1496.
  • 5Rayner J O,Dravga S A,Kamrud K I.Alphavirus vectors and vaccination[J].Rev Med Virol,2002,12(5):279-296.
  • 6Lundstrom K.Semliki forest virus vectors for gene therapy[J].Expert Opin Biol Ther,2003,3(5):771-777.
  • 7Varughese M,Teixeira A V,Liu S H,et al.Identification of a receptor-binding region within domain4of the protective anti-gen component of anthrax toxin[J].Infect immun,1999,67(4):1860-1865.
  • 8Flick-Smith H C,Walker N J,Gibson P,et al.A recombinantcarboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection[J].Infect im-mun,2002,70(3):1653-1656.
  • 9Yu Y Z,Li N,Wang W B,et al.Distinct immune responses of recombinant plasmid DNA replicon vaccines expressing two types of antigens with or without signal sequences[J].Vaccine,2010,28(47):7529-7535.
  • 10Turton K,Chaddock JA,Acharya KR.Botulinum and tetanus neurotoxtins: structure, function and therapeutic utility. Trends Biochem Sci, 2002, 27(11): 552-558.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部